Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by N00bInvesT0Ron Apr 15, 2019 2:40pm
133 Views
Post# 29629172

RE:RE:Aphria is a real diamond

RE:RE:Aphria is a real diamond
skyplt wrote: This is precisely why I am holding on despite the grind.

I appreciate that Aphria was lagging last Fall when we all thought it should have been doing better relative to its peers.  Sadly we now know why (thank you Vic/Andy).

I cannot help but think the lingering distrust is what keeps this down.  Indeed, rec sales are not helping the sector, but sheesh, how long does this linger?  Your synopsis below has me bewildered (I came to similar numbers).

A billion dollar goal is a pretty bold statement, but Mr. Irwin seems serious, and he is bringing in serious board members.

Once again I hope this is another one of those days we will laugh about some day...just not today.

N00bInvesT0R wrote:
Aphria Net revenues  after excise taxes ( 73,582 M) : https://aphria.ca/wp-content/uploads/2019/04/aphria-Q3-2019-inerim-financial-statements.pdf

Weed Net revenues after excise taxes (83,048 M) :  https://www.canopygrowth.com/wp-content/uploads/2019/02/Canopy-Growth-Corporation_Q3_2019-Financial-Statements_FINAL.pdf

Aurora Net revenues after excise taxes (54,178 M) : https://aphria.ca/wp-content/uploads/2019/04/aphria-Q3-2019-inerim-financial-statements.pdf

Let me spare you the maths, Aphria has a market cap 4 times smaller than Aurora on top of having almost 5 times less outstanding shares (dilution horrible) yet they managed to outperform Aurora by 36%.

Aphria and Weed no dilution problems but Aphria almost 6.5 times small than Weed yet Weed only outperformed Aphria by 11%.

Doesn't take a genius to understand whats next for Aphria in terms of valuation if the market is willing to accept Weed and Aurora valuation after getting outshined by Aphria

(Yes I know its CC pharma and the Argentine company that generated the most, I can care less, at least Aphria acquisition brings value to shareholders unlike other Mj companies acquisitions)

Good luck





Yeah Latam is a 1 time thing. For the inventory and small sales, he made it clear, he rather have mother plants for the expansion of the other facilities, why force things and harm the future just to look good 1 quarter, I love his decision making. More automatisation and less expansive packaging, I really believe they have a good thing growing.
Bullboard Posts